ERECTILE DYSFUNCTION AFFECTS A LARGE SEGMENT of the male population, and in
most cases impaired relaxation of the smooth muscle cells in the corpus cavernosum and …

Sildenafil is an oral therapy for erectile dysfunction of a broad range of causes. By
selectively inhibiting phosphodiesterase type 5, it allows corpus cavernosum smooth muscle …

Sildenafil (Viagra™, Pfizer, Inc.) is a new orally effective therapy for the treatment of men
with erectile dysfunction (ED). It is a specific and selective inhibitor of phosphodiesterase …

Erectile dysfunction (ED) is defined as the consistent inability to obtain or maintain an
erection for satisfactory sexual relations. An estimated 20–30 million men suffer from some …

Under normal physiological conditions, following sexual stimulation, release of nitric oxide
(NO) from penile non-adrenergic, non-cholinergic nerves and the endothelium activates …

Sildenafil citrate, the first internationally approved and widely used oral agent for the
treatment of erectile dysfunction (ED), has revolutionized the treatment of ED throughout the …

Sildenafil citrate is marketed under the trademark name Viagra® and is widely used to treat
male erectile dysfunction; therapeutic uses of this medication for other diseases related to …

Conclusions In response to sexual stimulation, sildenafil effectively potentiates the natural
dilatation of arteries supplying blood to the penis and corpora cavernosa. The drug is well …

Sildenafil citrate (Viagra) is the first effective, orally administered agent for the management
of erectile dysfunction (ED). It is a potent and selective inhibitor of phosphodiesterase type 5 …

Sildenafil citrate, an oral therapy for erectile dysfunction, is a selective inhibitor of cyclic
guanosine monophosphate (cGMP)—specific phosphodiesterase type 5 (PDE5), the …